- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Harbor Medical Inc.
Total 3644 results
-
Lundquist Institute for Biomedical Innovation at...CompletedEnd-Stage Renal Disease | Chronic Renal FailureUnited States
-
Lundquist Institute for Biomedical Innovation at...RecruitingLong Haul COVID or Post Acute Sequella of COVID - PASC (U09.9)United States
-
Lundquist Institute for Biomedical Innovation at...Active, not recruitingSleep RestrictionUnited States
-
Lundquist Institute for Biomedical Innovation at...CompletedCoronary Artery Disease | Type 2 DiabetesUnited States
-
Lundquist Institute for Biomedical Innovation at...CompletedBlood Pressure | Endothelial DysfunctionUnited States
-
Lundquist Institute for Biomedical Innovation at...TerminatedMucopolysaccharidosis I | Mucopolysaccharidosis II | Mucopolysaccharidosis VIUnited States
-
Lundquist Institute for Biomedical Innovation at...UnknownMigraine DisordersUnited States
-
Lundquist Institute for Biomedical Innovation at...Completed
-
Lundquist Institute for Biomedical Innovation at...CompletedEnd-stage Renal Disease | Chronic Kidney Failure | Disorders Associated With Peritoneal DialysisUnited States
-
Lundquist Institute for Biomedical Innovation at...UnknownOveractive BladderUnited States
-
Lundquist Institute for Biomedical Innovation at...Recruiting
-
Lundquist Institute for Biomedical Innovation at...Active, not recruitingCoronary Artery DiseaseUnited States
-
Lundquist Institute for Biomedical Innovation at...CompletedBone and Joint InfectionUnited States
-
Lundquist Institute for Biomedical Innovation at...Completed
-
Lundquist Institute for Biomedical Innovation at...CompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Lundquist Institute for Biomedical Innovation at...TerminatedA Comparison of Accuvein to Standard IV Access in Children 0 to 24 Months of Age in the Pediatric EDPediatric DisorderUnited States
-
Lundquist Institute for Biomedical Innovation at...Withdrawn
-
Lundquist Institute for Biomedical Innovation at...CompletedCoronary Stenosis | Coronary Artery Calcification | Coronary AtherosclerosisUnited States
-
Lundquist Institute for Biomedical Innovation at...Completed
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Millennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
Broncus Medical IncUptake Medical Technology, Inc.Unknown
-
Broncus Medical IncUptake Medical Technology, Inc.TerminatedLung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small CellChina
-
University Medical Centre MariborFaculty of Medicine, University of MariborCompletedSelf-Injurious Behavior | Self Injurious Behavior Without Suicidal Intent
-
University Medical Centre LjubljanaUniversity Medical Centre MariborCompletedPregnancy | Yoga | Autonomic Nervous SystemSlovenia
-
Dana-Farber Cancer InstituteSecura Bio, Inc.RecruitingChronic Lymphocytic Leukemia | Richter SyndromeUnited States
-
Dana-Farber Cancer InstituteNanoString Technologies, Inc.Active, not recruiting
-
Dana-Farber Cancer InstituteBiohaven Pharmaceuticals, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.Terminated
-
Dana-Farber Cancer InstituteMyriad Genetics, Inc.Active, not recruitingBreast Cancer | Invasive Breast Cancer | Genetic Testing | in Situ Breast CancerUnited States
-
Dana-Farber Cancer InstituteSecura Bio, Inc.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; ExelixisCompletedBreast Cancer | Brain Tumor - MetastaticUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteAMAG Pharmaceuticals, Inc.WithdrawnEsophageal Cancer
-
Dana-Farber Cancer InstituteGenentech, Inc.; BiogenCompleted
-
Biohaven Pharmaceuticals, Inc.Dana-Farber Cancer InstituteRecruitingMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteAbbVie; Genentech, Inc.RecruitingAcute Myeloid LeukemiaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedThyroid Cancer | Differentiated Thyroid Cancer | Anaplastic Thyroid CancerUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.Completed
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedChronic Graft Versus Host DiseaseUnited States
-
University Medical Centre LjubljanaUniversity Medical Centre MariborCompleted
-
Lundquist Institute for Biomedical Innovation at...PfizerNot yet recruitingArthritis, RheumatoidUnited States
-
Dana-Farber Cancer InstituteProgenics Pharmaceuticals, Inc.Not yet recruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Castration-resistant Prostate CarcinomaUnited States
-
Dana-Farber Cancer InstituteStemline Therapeutics, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Blastic Plasmacytoid Dendritic Cell NeoplasmUnited States
-
Dana-Farber Cancer InstituteNanoString Technologies, Inc.Active, not recruiting
-
Dana-Farber Cancer InstituteAVEO Pharmaceuticals, Inc.CompletedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteAstellas Pharma IncTerminatedNon-Small Cell Lung Cancer | Epidermal Growth Factor ReceptorUnited States
-
Dana-Farber Cancer InstituteLeadiant Biosciences, Inc.TerminatedT-Cell Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States